Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Indivior Shares Update On Aelis Farma's Phase 2B Study With AEF0117 In Participants With Cannabis Use Disorder

Author: Benzinga Newsdesk | September 04, 2024 02:35am
  • Primary and Secondary End Points of the Study were Not Met
  • Indivior Does Not Currently Expect to Exercise AEF0117 Option 

Posted In: INDV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist